Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03988101

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03988101
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03988101. Randomized; triple masking; primary purpose treatment. Start 2019-09-19 (actual); primary completion 2024-03-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event
Condition
Venous Thromboembolism
Condition
Dyslipidemias
Intervention (Drug)
Rosuvastatin 20mg
Intervention (Drug)
Control
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct03988101
Content hash
90bcac082609140e8da91047cfb3828bdb75247663263ac70a2c441cf103cecc